Kiora Pharmaceuticals, Inc. (KPRX)
2.53
+0.02
(+0.80%)
USD |
NASDAQ |
Sep 09, 13:58
Kiora Pharmaceuticals 1 Year Total Returns (Daily) : -6.60% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | -6.60% |
| September 04, 2026 | -6.59% |
| September 03, 2026 | -8.93% |
| September 02, 2026 | -5.13% |
| September 01, 2026 | -9.71% |
| August 31, 2026 | -9.71% |
| August 28, 2026 | -5.76% |
| August 27, 2026 | -6.99% |
| August 26, 2026 | -8.83% |
| August 25, 2026 | -2.26% |
| August 24, 2026 | 0.73% |
| August 21, 2026 | 1.53% |
| August 20, 2026 | -1.13% |
| August 19, 2026 | -2.62% |
| August 18, 2026 | -10.07% |
| August 17, 2026 | -11.60% |
| August 14, 2026 | 0.79% |
| August 13, 2026 | 4.02% |
| August 12, 2026 | 5.60% |
| August 11, 2026 | 6.94% |
| August 10, 2026 | 9.32% |
| August 07, 2026 | 10.46% |
| August 06, 2026 | 5.35% |
| August 05, 2026 | 1.60% |
| August 04, 2026 | -2.76% |
| Date | Value |
|---|---|
| August 03, 2026 | 1.97% |
| July 31, 2026 | -1.54% |
| July 30, 2026 | -4.66% |
| July 29, 2026 | -6.20% |
| July 28, 2026 | -12.29% |
| July 27, 2026 | -15.05% |
| July 24, 2026 | -16.39% |
| July 23, 2026 | -19.61% |
| July 22, 2026 | -16.50% |
| July 21, 2026 | -18.12% |
| July 20, 2026 | -18.24% |
| July 17, 2026 | -16.51% |
| July 16, 2026 | -19.05% |
| July 15, 2026 | -17.33% |
| July 14, 2026 | -19.48% |
| July 13, 2026 | -18.00% |
| July 10, 2026 | -16.61% |
| July 09, 2026 | -14.14% |
| July 08, 2026 | -10.84% |
| July 07, 2026 | -9.25% |
| July 06, 2026 | -10.53% |
| July 02, 2026 | -8.04% |
| July 01, 2026 | -5.67% |
| June 30, 2026 | -8.68% |
| June 29, 2026 | -10.00% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ANI Pharmaceuticals, Inc. | -26.23% |
| Corcept Therapeutics, Inc. | 60.02% |
| Veru, Inc. | -23.44% |
| Johnson & Johnson | 54.48% |
| Eli Lilly & Co. | 53.12% |